Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Genoty** may improve risk stratification of high‐risk (HR) human papillomavirus (HPV)‐
positive women in cervical screening programs; however, prospective data comparing the …

This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Description: Update of the 2003 US Preventive Services Task Force (USPSTF) …

A vast range of disorders—from indolent to fast-growing lesions—are labelled as cancer.
Therefore, we believe that several changes should be made to the approach to cancer …

Background Cervical cancer screening has traditionally been based on cervical cytology.
Given the aetiological relationship between human papillomavirus (HPV) infection and …

Strong evidence now supports the adoption of cervical cancer prevention strategies that
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …

Background The ATHENA study was designed to assess the performance of carcinogenic
human papillomavirus (HPV) testing and HPV16 or HPV18 genoty** compared with liquid …

The discovery that certain high-risk strains of human papillomavirus (HR-HPV) cause nearly
100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by …

In a project coordinated by the International Agency for Research on Cancer (IARC) 31
experts from 11 European countries and IARC have developed supplements to the current …